Skip to main content
Clinical Trials/IRCT2013112215490N1
IRCT2013112215490N1CompletedPhase 2

Evaluation of the prophylactic effect of amiodarone in reducing the incidence of atrial fibrilation after coronary bypass graft surgery

Arak University of Medical Sciences, Vice Chancellor for Research0 sites204 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
204

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
35 years to 70 years (—)
Sex
All

Inclusion Criteria

  • 1.All patients candidate for CABG
  • 2.All patients with ASA II and III.
  • 3.All surveyed patients are candidate for 2 or 3 grafts.
  • Exclusion criteria:
  • 1.Patients candidate for more than 3 grafts.
  • 2.Incidence of any arrhythmia in placebo group.
  • 3.Incidence of any arrhythmia other than atrial fibrillation in the amiodarone group.

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Arak University of Medical Sciences, Vice Chancellor for Research

Similar Trials